lncRNAs: potential therapeutic targets and biomarkers for pancreatic cancer?

Research output: Contribution to journal › Editorial › Research

Standard

lncRNAs : potential therapeutic targets and biomarkers for pancreatic cancer? / Montes, Marta; Arnes, Luis.

In: Expert Opinion On Therapeutic Targets, Vol. 25, No. 7, 2021, p. 521-528.

Research output: Contribution to journal › Editorial › Research

Harvard

Montes, M & Arnes, L 2021, 'lncRNAs: potential therapeutic targets and biomarkers for pancreatic cancer?', Expert Opinion On Therapeutic Targets, vol. 25, no. 7, pp. 521-528. https://doi.org/10.1080/14728222.2021.1938541

APA

Montes, M., & Arnes, L. (2021). lncRNAs: potential therapeutic targets and biomarkers for pancreatic cancer? Expert Opinion On Therapeutic Targets, 25(7), 521-528. https://doi.org/10.1080/14728222.2021.1938541

Vancouver

Montes M, Arnes L. lncRNAs: potential therapeutic targets and biomarkers for pancreatic cancer? Expert Opinion On Therapeutic Targets. 2021;25(7):521-528. https://doi.org/10.1080/14728222.2021.1938541

Author

Montes, Marta ; Arnes, Luis. / lncRNAs : potential therapeutic targets and biomarkers for pancreatic cancer?. In: Expert Opinion On Therapeutic Targets. 2021 ; Vol. 25, No. 7. pp. 521-528.

Bibtex

@article{4001d12012b2439da07bd94b37973143,
title = "lncRNAs: potential therapeutic targets and biomarkers for pancreatic cancer?",
keywords = "acquired resistance, biomarkers, enhancers, lncRNAs, molecular subtypes, Pancreatic ductal adenocarcinoma, targeted therapy",
author = "Marta Montes and Luis Arnes",
note = "Funding Information: We thank all members of the Arnes laboratory for critical reading of the manuscript and helpful discussion. The Novo Nordisk Foundation Center for Stem Cell Biology is supported by grant number NNF17CC0027852. ",
year = "2021",
doi = "10.1080/14728222.2021.1938541",
language = "English",
volume = "25",
pages = "521--528",
journal = "Expert Opinion on Therapeutic Targets",
issn = "1472-8222",
publisher = "Taylor & Francis",
number = "7",

}

RIS

TY - JOUR

T1 - lncRNAs

T2 - potential therapeutic targets and biomarkers for pancreatic cancer?

AU - Montes, Marta

AU - Arnes, Luis

N1 - Funding Information: We thank all members of the Arnes laboratory for critical reading of the manuscript and helpful discussion. The Novo Nordisk Foundation Center for Stem Cell Biology is supported by grant number NNF17CC0027852.

PY - 2021

Y1 - 2021

KW - acquired resistance

KW - biomarkers

KW - enhancers

KW - lncRNAs

KW - molecular subtypes

KW - Pancreatic ductal adenocarcinoma

KW - targeted therapy

U2 - 10.1080/14728222.2021.1938541

DO - 10.1080/14728222.2021.1938541

M3 - Editorial

C2 - 34077329

AN - SCOPUS:85112213060

VL - 25

SP - 521

EP - 528

JO - Expert Opinion on Therapeutic Targets

JF - Expert Opinion on Therapeutic Targets

SN - 1472-8222

IS - 7

ER -

ID: 276377894